Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ThermoProfen is an investigational transdermal ketoprofen patch that incorporates ZARS Pharma’s Controlled Heat-Assisted Drug Delivery (CHADD) technology to provide localized delivery of the nonsteroidal anti-inflammatory drug ketoprofen together with therapeutic heat for musculoskeletal pain relief.[4][7][19] As a topical NSAID system, ThermoProfen is designed to inhibit cyclooxygenase-mediated prostaglandin synthesis at the site of application, thereby reducing inflammation and pain while potentially limiting systemic exposure compared with oral NSAIDs.[19][22] Developed by ZARS Pharma as its lead product candidate, ThermoProfen has undergone late-stage clinical evaluation, including a study in patients with mild to moderate chronic pain associated with osteoarthritis of the knee.[4][7][11][16][19]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ThermoProfen.